Understanding patient preferences for screening tests for Barrett's esophagus and esophageal cancer
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests: A Discrete Choice-Based Conjoint Analysis
This study is trying to understand what patients prefer when it comes to screening tests for Barrett's esophagus and esophageal cancer to help improve current practices.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 556 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Trial ID | NCT06693622 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather insights into patient preferences regarding screening for Barrett's esophagus and esophageal cancer. Through a multicenter discrete choice-based conjoint survey, patients will evaluate various screening test attributes, including sensitivity, convenience, procedural discomfort, and financial implications. The findings will help identify barriers and preferences that could inform modifications to current screening practices in the United States, ultimately aiming to reduce esophageal cancer mortality rates.
Who should consider this trial
Good fit: Ideal candidates include individuals over 50 years old with three or more risk factors for Barrett's esophagus, such as chronic GERD, male gender, and obesity.
Not a fit: Patients who have already been diagnosed with Barrett's esophagus or esophageal cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more patient-centered screening practices that improve early detection of esophageal cancer.
How similar studies have performed: While there have been studies on screening preferences, this specific approach using discrete choice modeling for Barrett's esophagus and esophageal cancer is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision to sign and date the consent form. * Stated willingness to comply with all study procedures and be available for the duration of the study. * Individual has 3 or more established risk factors for BE (age \> 50 years, chronic GERD, male, white race, smoking, obesity, family history of BE/EAC). Exclusion Criteria: * Unable to consent. * Prior diagnosis of BE/EAC. * Life limiting comorbidity/ disability. * Active dementia/ cognitive impairment. * Incarcerated.
Where this trial is running
Aurora, Colorado
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Sachin Wani, MD — University of Colorado, Denver
- Study coordinator: Alexa DeBord, MS
- Email: alexa.debord@cuanschutz.edu
- Phone: 303-724-0432
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.